A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632

Lung Cancer ◽  
2021 ◽  
Vol 161 ◽  
pp. 49-54
Author(s):  
Rintaro Noro ◽  
Satoshi Igawa ◽  
Akihiro Bessho ◽  
Takashi Hirose ◽  
Tsuneo Shimokawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Research Group ◽  
Low Dose ◽  
Egfr Mutation ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
Oncology Research ◽  
Prospective Phase

scholarly journals Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation–Positive Non–Small Cell Lung Cancer

JAMA Oncology ◽  
2020 ◽  
Vol 6 (7) ◽  
pp. e201250 ◽  
Author(s):  
Shingo Miyamoto ◽  
Koichi Azuma ◽  
Hidenobu Ishii ◽  
Akihiro Bessho ◽  
Shinobu Hosokawa ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Low Dose ◽  
Egfr Mutation ◽  
Small Cell ◽  
Small Cell Lung ◽  
Frail Patients
Sign in / Sign up

Export Citation Format

Share Document